Fountain syndrome
Fountain syndrome is a rare genetic disorder characterized by a combination of intellectual disability, hearing loss, growth retardation, and facial dysmorphism. The syndrome was first described in the medical literature in the late 20th century and is named after the physician who identified it.
Clinical Features[edit | edit source]
Individuals with Fountain syndrome typically present with the following clinical features:
- Intellectual disability: Affected individuals often exhibit varying degrees of cognitive impairment.
- Hearing loss: Sensorineural hearing loss is a common feature, which may range from mild to severe.
- Growth retardation: Delayed growth and short stature are frequently observed.
- Facial dysmorphism: Distinctive facial features may include a broad nasal bridge, wide-set eyes (hypertelorism), and a prominent forehead.
Genetics[edit | edit source]
Fountain syndrome is believed to follow an autosomal recessive inheritance pattern. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The specific gene or genes involved in Fountain syndrome have not yet been definitively identified.
Diagnosis[edit | edit source]
The diagnosis of Fountain syndrome is primarily based on clinical evaluation and the identification of characteristic features. Genetic testing may be used to support the diagnosis, particularly in cases where there is a family history of the disorder.
Management[edit | edit source]
There is currently no cure for Fountain syndrome, and treatment is primarily supportive and symptomatic. Management strategies may include:
- Special education programs to address intellectual disability.
- Hearing aids or other assistive devices for hearing loss.
- Regular monitoring of growth and development.
- Multidisciplinary care involving pediatricians, geneticists, audiologists, and other specialists.
Prognosis[edit | edit source]
The prognosis for individuals with Fountain syndrome varies depending on the severity of the symptoms. Early intervention and supportive care can improve the quality of life for affected individuals.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD